Published 11 hours ago • loading... • Updated 2 hours ago

Wall Street Researchers Used Claude to Design Drug Candidates, and the Trade Is in the Lab

Citrini Research used Anthropic's Claude Science to design scorpion antivenom candidates, sparking a thesis favoring Charles River and Revvity.

4 Articles

Bloomberg

Center

Citrini Bets on Life Sciences Stocks After Claude AI Drug Study

Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.

11 hours ago·New York, United States

Read Full Article

TokenPost

Citrini Research Names Charles River, Revvity in AI Drug Thesis

The firm's case rests on faster drug candidate design leading to more laboratory testing, an increase it has not established.

2 hours ago

Read Full Article

DiarioBitcoin

Claude Accelerated Drug Design, but Citrini Sees the Opportunity in the Labs

A Citrini Research exercise with Claude generated molecular candidates in days, but synthesis and laboratory testing remained necessary.The firm sees a potential investment opportunity in the companies that validate those designs.

5 hours ago

Read Full Article